Click here to get full coverage on MeiraGTx Holdings (MGTX) Q3 Loss Of US$50.5m Reinforces Bearish Community Narratives - simplywall.st

MeiraGTx Holdings (MGTX) Q3 Loss Of US$50.5m Reinforces Bearish Community Narratives  simplywall.st

MeiraGTx Holdings (MGTX) Q3 Loss Of US$50.5m Reinforces Bearish Community Narratives - simplywall.st

Click here to get full coverage on Piper Sandler Lowers MeiraGTx (NASDAQ:MGTX) Price Target to $26.00 - MarketBeat

Piper Sandler Lowers MeiraGTx (NASDAQ:MGTX) Price Target to $26.00  MarketBeat

Piper Sandler Lowers MeiraGTx (NASDAQ:MGTX) Price Target to $26.00 - MarketBeat

Click here to get full coverage on MeiraGTx Holdings PLC (MGTX) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance

MeiraGTx Holdings PLC (MGTX) Q4 Earnings and Revenues Surpass Estimates  Yahoo Finance

MeiraGTx Holdings PLC (MGTX) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance

Click here to get full coverage on MGTX SEC Filings - Meiragtx Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan

MGTX SEC Filings - Meiragtx Holdings Plc 10-K, 10-Q, 8-K Forms  Stock Titan

MGTX SEC Filings - Meiragtx Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan

Click here to get full coverage on Forbes Alexandria, president & CEO of MeiraGTx, sells $459k in MGTX stock - Investing.com

Forbes Alexandria, president & CEO of MeiraGTx, sells $459k in MGTX stock  Investing.com

Forbes Alexandria, president & CEO of MeiraGTx, sells $459k in MGTX stock - Investing.com

Click here to get full coverage on MeiraGTx (NASDAQ:MGTX) Issues Earnings Results - MarketBeat

MeiraGTx (NASDAQ:MGTX) Issues Earnings Results  MarketBeat

MeiraGTx (NASDAQ:MGTX) Issues Earnings Results - MarketBeat

Click here to get full coverage on MGTX Receives Breakthrough Designation for Xerostomia Treatment - GuruFocus

MGTX Receives Breakthrough Designation for Xerostomia Treatment  GuruFocus

MGTX Receives Breakthrough Designation for Xerostomia Treatment - GuruFocus

Click here to get full coverage on How (MGTX) Movements Inform Risk Allocation Models - Stock Traders Daily

How (MGTX) Movements Inform Risk Allocation Models  Stock Traders Daily

How (MGTX) Movements Inform Risk Allocation Models - Stock Traders Daily

Click here to get full coverage on MeiraGTx Extends Perceptive Notes to May 2027, Plans $25M Redemption; Warrants Repriced to $8 - TradingView

MeiraGTx Extends Perceptive Notes to May 2027, Plans $25M Redemption; Warrants Repriced to $8  TradingView

MeiraGTx Extends Perceptive Notes to May 2027, Plans $25M Redemption; Warrants Repriced to $8 - TradingView

Click here to get full coverage on MeiraGTx (Nasdaq: MGTX) gains FDA breakthrough tag and extends debt maturity - Stock Titan

MeiraGTx (Nasdaq: MGTX) gains FDA breakthrough tag and extends debt maturity  Stock Titan

MeiraGTx (Nasdaq: MGTX) gains FDA breakthrough tag and extends debt maturity - Stock Titan

Click here to get full coverage on MeiraGTx Holdings plc (NASDAQ:MGTX) has caught the attention of institutional investors who hold a sizeable 31% stake - Yahoo Finance

MeiraGTx Holdings plc (NASDAQ:MGTX) has caught the attention of institutional investors who hold a sizeable 31% stake  Yahoo Finance

MeiraGTx Holdings plc (NASDAQ:MGTX) has caught the attention of institutional investors who hold a sizeable 31% stake - Yahoo Finance

Click here to get full coverage on MeiraGTx (NASDAQ:MGTX) Price Target Raised to $16.00 at Bank of America - MarketBeat

MeiraGTx (NASDAQ:MGTX) Price Target Raised to $16.00 at Bank of America  MarketBeat

MeiraGTx (NASDAQ:MGTX) Price Target Raised to $16.00 at Bank of America - MarketBeat

Click here to get full coverage on FDA grants breakthrough status to MeiraGTx dry-mouth gene therapy - Stock Titan

FDA grants breakthrough status to MeiraGTx dry-mouth gene therapy  Stock Titan

FDA grants breakthrough status to MeiraGTx dry-mouth gene therapy - Stock Titan

Click here to get full coverage on MeiraGTx (NASDAQ:MGTX) Earns Buy Rating from Chardan Capital - MarketBeat

MeiraGTx (NASDAQ:MGTX) Earns Buy Rating from Chardan Capital  MarketBeat

MeiraGTx (NASDAQ:MGTX) Earns Buy Rating from Chardan Capital - MarketBeat

Click here to get full coverage on MeiraGTx (MGTX) Moves 12.4% Higher: Will This Strength Last? - Yahoo Finance

MeiraGTx (MGTX) Moves 12.4% Higher: Will This Strength Last?  Yahoo Finance

MeiraGTx (MGTX) Moves 12.4% Higher: Will This Strength Last? - Yahoo Finance

Click here to get full coverage on MeiraGTx (MGTX) CEO sells 62K shares at $7.41 under 10b5-1 plan - Stock Titan

MeiraGTx (MGTX) CEO sells 62K shares at $7.41 under 10b5-1 plan  Stock Titan

MeiraGTx (MGTX) CEO sells 62K shares at $7.41 under 10b5-1 plan - Stock Titan

Click here to get full coverage on [144] MeiraGTx Holdings plc SEC Filing - Stock Titan

[144] MeiraGTx Holdings plc SEC Filing  Stock Titan

[144] MeiraGTx Holdings plc SEC Filing - Stock Titan

Click here to get full coverage on MeiraGTx (NASDAQ:MGTX) Sees Strong Trading Volume - Should You Buy? - MarketBeat

MeiraGTx (NASDAQ:MGTX) Sees Strong Trading Volume - Should You Buy?  MarketBeat

MeiraGTx (NASDAQ:MGTX) Sees Strong Trading Volume - Should You Buy? - MarketBeat

Click here to get full coverage on Gene therapy firm MeiraGTx's 2025 net loss narrows - TradingView

Gene therapy firm MeiraGTx's 2025 net loss narrows  TradingView

Gene therapy firm MeiraGTx's 2025 net loss narrows - TradingView

Click here to get full coverage on MeiraGTx (MGTX) to Release Quarterly Earnings on Thursday - MarketBeat

MeiraGTx (MGTX) to Release Quarterly Earnings on Thursday  MarketBeat

MeiraGTx (MGTX) to Release Quarterly Earnings on Thursday - MarketBeat

Click here to get full coverage on Analysts Have Lowered Expectations For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its Latest Results - simplywall.st

Analysts Have Lowered Expectations For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its Latest Results  simplywall.st

Analysts Have Lowered Expectations For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its Latest Results - simplywall.st

Click here to get full coverage on MeiraGTx Holdings PLC (MGTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance

MeiraGTx Holdings PLC (MGTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release  Yahoo Finance

MeiraGTx Holdings PLC (MGTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance

Click here to get full coverage on MeiraGTx Holdings plc (MGTX) Stock Price Prediction for 2026, 2030-2040 - Traders Union

MeiraGTx Holdings plc (MGTX) Stock Price Prediction for 2026, 2030-2040  Traders Union

MeiraGTx Holdings plc (MGTX) Stock Price Prediction for 2026, 2030-2040 - Traders Union

Click here to get full coverage on MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts  MarketBeat

MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Click here to get full coverage on MeiraGTx Highlights Breakthrough Gene Therapy and Strategic Alliances - TipRanks

MeiraGTx Highlights Breakthrough Gene Therapy and Strategic Alliances  TipRanks

MeiraGTx Highlights Breakthrough Gene Therapy and Strategic Alliances - TipRanks

Click here to get full coverage on There's Reason For Concern Over MeiraGTx Holdings plc's (NASDAQ:MGTX) Price - simplywall.st

There's Reason For Concern Over MeiraGTx Holdings plc's (NASDAQ:MGTX) Price  simplywall.st

There's Reason For Concern Over MeiraGTx Holdings plc's (NASDAQ:MGTX) Price - simplywall.st

Click here to get full coverage on MeiraGTx shares see Raymond James price target cut on launch timing - Investing.com

MeiraGTx shares see Raymond James price target cut on launch timing  Investing.com

MeiraGTx shares see Raymond James price target cut on launch timing - Investing.com

Click here to get full coverage on Piper Sandler cuts MeiraGTx stock price target on valuation By Investing.com - Investing.com UK

Piper Sandler cuts MeiraGTx stock price target on valuation By Investing.com  Investing.com UK

Piper Sandler cuts MeiraGTx stock price target on valuation By Investing.com - Investing.com UK

Click here to get full coverage on MeiraGTx (NASDAQ:MGTX) Sees Strong Trading Volume - Time to Buy? - MarketBeat

MeiraGTx (NASDAQ:MGTX) Sees Strong Trading Volume - Time to Buy?  MarketBeat

MeiraGTx (NASDAQ:MGTX) Sees Strong Trading Volume - Time to Buy? - MarketBeat

Click here to get full coverage on MeiraGTx inks $18.2M share purchase deal with Perceptive Advisors - Seeking Alpha

MeiraGTx inks $18.2M share purchase deal with Perceptive Advisors  Seeking Alpha

MeiraGTx inks $18.2M share purchase deal with Perceptive Advisors - Seeking Alpha

Click here to get full coverage on MeiraGTx (NASDAQ:MGTX) Upgraded by Zacks Research to Hold Rating - MarketBeat

MeiraGTx (NASDAQ:MGTX) Upgraded by Zacks Research to Hold Rating  MarketBeat

MeiraGTx (NASDAQ:MGTX) Upgraded by Zacks Research to Hold Rating - MarketBeat

Click here to get full coverage on MeiraGTx earnings beat by $0.75, revenue topped estimates - Investing.com

MeiraGTx earnings beat by $0.75, revenue topped estimates  Investing.com

MeiraGTx earnings beat by $0.75, revenue topped estimates - Investing.com

Click here to get full coverage on MeiraGTx Holdings (NASDAQ:MGTX) Is Making Moderate Use Of Debt - simplywall.st

MeiraGTx Holdings (NASDAQ:MGTX) Is Making Moderate Use Of Debt  simplywall.st

MeiraGTx Holdings (NASDAQ:MGTX) Is Making Moderate Use Of Debt - simplywall.st

Click here to get full coverage on Trading Systems Reacting to (MGTX) Volatility - Stock Traders Daily

Trading Systems Reacting to (MGTX) Volatility  Stock Traders Daily

Trading Systems Reacting to (MGTX) Volatility - Stock Traders Daily

Click here to get full coverage on MeiraGTx Stock: Hologen Partnership Makes Parkinson’s Gene Therapy Vital (NASDAQ:MGTX) - Seeking Alpha

MeiraGTx Stock: Hologen Partnership Makes Parkinson’s Gene Therapy Vital (NASDAQ:MGTX)  Seeking Alpha

MeiraGTx Stock: Hologen Partnership Makes Parkinson’s Gene Therapy Vital (NASDAQ:MGTX) - Seeking Alpha

Click here to get full coverage on Insider Sell Alert: Alexandria Forbes Sells 62,000 Shares of Mei - GuruFocus

Insider Sell Alert: Alexandria Forbes Sells 62,000 Shares of Mei  GuruFocus

Insider Sell Alert: Alexandria Forbes Sells 62,000 Shares of Mei - GuruFocus

Click here to get full coverage on BofA raises MeiraGTx stock price target to $16 on FDA designation - Investing.com Australia

BofA raises MeiraGTx stock price target to $16 on FDA designation  Investing.com Australia

BofA raises MeiraGTx stock price target to $16 on FDA designation - Investing.com Australia

Click here to get full coverage on MeiraGTx: Latest Eli Lilly Partnership Ignites Riboswitch Technology Potential (MGTX) - Seeking Alpha

MeiraGTx: Latest Eli Lilly Partnership Ignites Riboswitch Technology Potential (MGTX)  Seeking Alpha

MeiraGTx: Latest Eli Lilly Partnership Ignites Riboswitch Technology Potential (MGTX) - Seeking Alpha

Click here to get full coverage on MeiraGTx (MGTX) CMO reports RSU vesting and tax-share withholding on Form 4 - Stock Titan

MeiraGTx (MGTX) CMO reports RSU vesting and tax-share withholding on Form 4  Stock Titan

MeiraGTx (MGTX) CMO reports RSU vesting and tax-share withholding on Form 4 - Stock Titan

Click here to get full coverage on Latest MGTX News - MeiraGTx Announces FDA Breakthrough Therapy... - Stock Titan

Latest MGTX News - MeiraGTx Announces FDA Breakthrough Therapy...  Stock Titan

Latest MGTX News - MeiraGTx Announces FDA Breakthrough Therapy... - Stock Titan

Click here to get full coverage on MeiraGTx (MGTX) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

MeiraGTx (MGTX) FDA Approvals, PDUFA Dates & Drug Alerts 2026  MarketBeat

MeiraGTx (MGTX) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

Click here to get full coverage on MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle? - Stocktwits

MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle?  Stocktwits

MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle? - Stocktwits

Click here to get full coverage on Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease - Reuters

Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease  Reuters

Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease - Reuters

Click here to get full coverage on MeiraGTx earnings beat by $0.75, revenue topped estimates - Investing.com Canada

MeiraGTx earnings beat by $0.75, revenue topped estimates  Investing.com Canada

MeiraGTx earnings beat by $0.75, revenue topped estimates - Investing.com Canada

Click here to get full coverage on MeiraGTx Holdings enters agreement to repurchase 2.3 million shares from Perceptive - Investing.com

MeiraGTx Holdings enters agreement to repurchase 2.3 million shares from Perceptive  Investing.com

MeiraGTx Holdings enters agreement to repurchase 2.3 million shares from Perceptive - Investing.com

Click here to get full coverage on Time To Eye MeiraGTx As Shares Hit New 52-Week High? - RTTNews

Time To Eye MeiraGTx As Shares Hit New 52-Week High?  RTTNews

Time To Eye MeiraGTx As Shares Hit New 52-Week High? - RTTNews

Click here to get full coverage on MeiraGTx shares see Raymond James price target cut on launch timing - Investing.com Canada

MeiraGTx shares see Raymond James price target cut on launch timing  Investing.com Canada

MeiraGTx shares see Raymond James price target cut on launch timing - Investing.com Canada

Click here to get full coverage on The MGTX Trial - The New England Journal of Medicine

The MGTX Trial  The New England Journal of Medicine

The MGTX Trial - The New England Journal of Medicine

Click here to get full coverage on Forbes Alexandria, MeiraGTx CEO, sells $398k in shares - Investing.com

Forbes Alexandria, MeiraGTx CEO, sells $398k in shares  Investing.com

Forbes Alexandria, MeiraGTx CEO, sells $398k in shares - Investing.com

Click here to get full coverage on MeiraGTx earnings beat by $0.75, revenue topped estimates - Investing.com India

MeiraGTx earnings beat by $0.75, revenue topped estimates  Investing.com India

MeiraGTx earnings beat by $0.75, revenue topped estimates - Investing.com India

Click here to get full coverage on Aug Highlights: Does MGTX have a competitive edge - 2026 Top Gainers & Safe Capital Allocation Plans - baoquankhu1.vn

Aug Highlights: Does MGTX have a competitive edge - 2026 Top Gainers & Safe Capital Allocation Plans  baoquankhu1.vn

Aug Highlights: Does MGTX have a competitive edge - 2026 Top Gainers & Safe Capital Allocation Plans - baoquankhu1.vn

Click here to get full coverage on MGTX Forecast — Price Prediction for 2026. Should I Buy MGTX? - Intellectia AI

MGTX Forecast — Price Prediction for 2026. Should I Buy MGTX?  Intellectia AI

MGTX Forecast — Price Prediction for 2026. Should I Buy MGTX? - Intellectia AI

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on MeiraGTx Holdings plc (NASDAQ:MGTX) - intelligentinvestor.com.au

MeiraGTx Holdings plc (NASDAQ:MGTX)  intelligentinvestor.com.au

MeiraGTx Holdings plc (NASDAQ:MGTX) - intelligentinvestor.com.au

Click here to get full coverage on MeiraGTx Holdings plc (MGTX): Is This Gene Therapy Stock a Good Buy Right Now? - Yahoo Finance

MeiraGTx Holdings plc (MGTX): Is This Gene Therapy Stock a Good Buy Right Now?  Yahoo Finance

MeiraGTx Holdings plc (MGTX): Is This Gene Therapy Stock a Good Buy Right Now? - Yahoo Finance

Click here to get full coverage on 3 Promising Genomics Stocks to Keep an Eye On in 2025 - Zacks Investment Research

3 Promising Genomics Stocks to Keep an Eye On in 2025  Zacks Investment Research

3 Promising Genomics Stocks to Keep an Eye On in 2025 - Zacks Investment Research

Click here to get full coverage on MeiraGTx to Repurchase 2.3 Million Shares for $18.2 Million - marketscreener.com

MeiraGTx to Repurchase 2.3 Million Shares for $18.2 Million  marketscreener.com

MeiraGTx to Repurchase 2.3 Million Shares for $18.2 Million - marketscreener.com

Click here to get full coverage on MeiraGTx Holdings Stock (ISIN: US58550P1012) Faces Earnings Spotlight Amid Volatility and Analyst Op - AD HOC NEWS

MeiraGTx Holdings Stock (ISIN: US58550P1012) Faces Earnings Spotlight Amid Volatility and Analyst Op  AD HOC NEWS

MeiraGTx Holdings Stock (ISIN: US58550P1012) Faces Earnings Spotlight Amid Volatility and Analyst Op - AD HOC NEWS

Click here to get full coverage on MeiraGTx (MGTX) Stock Forecast and Price Target 2026 - MarketBeat

MeiraGTx (MGTX) Stock Forecast and Price Target 2026  MarketBeat

MeiraGTx (MGTX) Stock Forecast and Price Target 2026 - MarketBeat

Click here to get full coverage on What is the current Price Target and Forecast for MeiraGTx (MGTX) - Zacks Investment Research

What is the current Price Target and Forecast for MeiraGTx (MGTX)  Zacks Investment Research

What is the current Price Target and Forecast for MeiraGTx (MGTX) - Zacks Investment Research

Click here to get full coverage on MGTX Stock Price | Analyst Target 14.00 & Consensus - eToro

MGTX Stock Price | Analyst Target 14.00 & Consensus  eToro

MGTX Stock Price | Analyst Target 14.00 & Consensus - eToro

Click here to get full coverage on Graviton Bioscience Announces Strategic Investment from Sanofi to Advance Development of the Next Generation of Selective ROCK2 Inhibitors - PR Newswire

Graviton Bioscience Announces Strategic Investment from Sanofi to Advance Development of the Next Generation of Selective ROCK2 Inhibitors  PR Newswire

Graviton Bioscience Announces Strategic Investment from Sanofi to Advance Development of the Next Generation of Selective ROCK2 Inhibitors - PR Newswire

Click here to get full coverage on What date does MeiraGTx's (MGTX) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research

What date does MeiraGTx's (MGTX) report Earnings - Earnings Calendar & Announcement  Zacks Investment Research

What date does MeiraGTx's (MGTX) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research

Click here to get full coverage on MeiraGTx earnings missed, revenue fell short of estimates By Investing.com - Investing.com UK

MeiraGTx earnings missed, revenue fell short of estimates By Investing.com  Investing.com UK

MeiraGTx earnings missed, revenue fell short of estimates By Investing.com - Investing.com UK

Click here to get full coverage on Randomized Trial of Thymectomy in Myasthenia Gravis - The New England Journal of Medicine

Randomized Trial of Thymectomy in Myasthenia Gravis  The New England Journal of Medicine

Randomized Trial of Thymectomy in Myasthenia Gravis - The New England Journal of Medicine

Click here to get full coverage on MeiraGTx (MGTX) - Zacks Investment Research

MeiraGTx (MGTX)  Zacks Investment Research

MeiraGTx (MGTX) - Zacks Investment Research

Click here to get full coverage on Meiragtx Holdings Stock Price Forecast. Should You Buy MGTX? - StockInvest.us

Meiragtx Holdings Stock Price Forecast. Should You Buy MGTX?  StockInvest.us

MGTX

Price Chart

Key Statistics

Technicals

About MGTX

Latest News

MeiraGTx Holdings (MGTX) Q3 Loss Of US$50.5m Reinforces Bearish Community Narratives - simplywall.st

Piper Sandler Lowers MeiraGTx (NASDAQ:MGTX) Price Target to $26.00 - MarketBeat

MeiraGTx Holdings PLC (MGTX) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers